secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rein Therapeutics, Inc. (RNTX)
CIK:        0001420565
Form:       8-K
Filed at:   2024-01-29T23:59:59+00:00
Accession:  0001193125-24-017476
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.08, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Aileron sets deadlines for shareholder proposals and director nominations for Feb 2024 annual meeting
--------------------------------------------------------------------------------

- Annual meeting scheduled for February 28, 2024; no 2023 meeting was held.
- Deadline for Rule 14a-8 stockholder proposals: January 29, 2024.
- Deadline for director nominations under bylaws: February 8, 2024.
- Submission address: 738 Main Street #398, Waltham, MA 02451.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420565/000119312524017476/0001193125-24-017476-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420565/000119312524017476/d103474d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-017476

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer